NICLOCIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Niclocide, and when can generic versions of Niclocide launch?
Niclocide is a drug marketed by Bayer Pharms and is included in one NDA.
The generic ingredient in NICLOCIDE is niclosamide. There are three drug master file entries for this compound. Additional details are available on the niclosamide profile page.
Summary for NICLOCIDE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 104 |
Patent Applications: | 3,401 |
Formulation / Manufacturing: | see details |
DailyMed Link: | NICLOCIDE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for NICLOCIDE
US Patents and Regulatory Information for NICLOCIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bayer Pharms | NICLOCIDE | niclosamide | TABLET, CHEWABLE;ORAL | 018669-001 | May 14, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |